A trial participant has been denied’ the promise of the Covid-19 vaccine due to a negative reaction.
A spokeswoman for AstraZeneca, a company
that works with the Oxford University team, told the Guardian that one of the
participants had been put’ on trial for "potentially unknown
illness".
The spokesman stressed that adverse
reactions were recorded in only one participant, and said that it was common to
stop trials during vaccine’ development.
The spokesman said in a statement:
"As part of the ongoing randomized, controlled global trial of the Oxford
coronavirus vaccine, our standard review process was activated and we
volunteered to provide safety data through an independent committee. Was
prevented’ from reviewing the data. "
"This is a normal procedure that has
to be done whenever there is an unknown disease in any trial, while it is being
investigated. This ensures that we maintain the integrity of the trials."
In large trials, the disease will be accidental, but it must be carefully
examined’ independently.
We're working to speed up review of the
same program to minimize any potential impact on the trial timeline. We adhere
to the highest standards of safety and conduct of our partners in our trials.
The vaccine, which was expected’ to be
available to the public by January 2021, is one of two projects under which the
Australian government has agreed to provide free vaccines to all citizens under
an agreement 1.7 It will cost billions of dollars.
On Monday, the Morrison government pledged
to buy 33.8 million doses of the vaccine, if successful.
In response to the announcement,
Australian Deputy Chief Medical Officer Nick Coatsworth said the trial
"would not in any way keep the vaccine completely off the table."
"In a way, it reinforces that despite
the rapid nature of vaccine development, safety is at the forefront of
everyone's mind and if there is a strong reaction, it will be a fair standard
and they will "I'm not sure if it's related to that. The vaccine,
too," he told the Seven Network.
"They are gathering all the
information and are currently on trial. We now have tens of thousands of people
receiving this vaccine, so it is a testament to the rigor and safety that
people are developing the vaccine for.
The Oxford University vaccine, which is to
be given’ in multiple doses, has entered three phases of trials in the United
Kingdom, the United States, Brazil, South Africa and India, and before that it
could provoke strong reactions from the immune system.
The British government attacked the
initial agreement for the vaccine, later increasing its order to 100 million
doses.
On Tuesday, the academics involved in the
trial wrote that it was one of six Covid 19 vaccines in the world that are
currently in the third phase - the final step before a vaccine is approved.
He wrote that the vaccine is being tested
in the UK by health workers as well as public volunteers over the age of 70.
As of Tuesday, 17,000 people in Britain,
Brazil and South Africa had already been vaccinated’ against polio.
Robert Booy, a professor of vaccinology at
the University of Sydney, told the Guardian that preventing a trial based on a
participant's reaction "is likely to be extremely careful to avoid."
In contrast, there is no problem with this vaccine.
Booy, who has previously worked on vaccine
development at Oxford, said he understood why the details of the adverse
reaction were not released’ as specific side effects and "stops"
could occur if the problem persisted. Too much detail can make the study
biased. “To be irregular
He said stopping the trial of the vaccine
was not uncommon.
"When you're vaccinating more than 10,000
people, coincidentally, there will be weird and wonderful things going on with
the participants that were going to happen anyway. The hearing needs to be,
stopped.
Booy believes the trial could resume
within a month if the possible co-investigation provides "reassuring
results", but said that if such negative reactions occur. If more cases
are reported’ more questions will be raised’ about vaccine safety.
"It could just be a high fever, and
it shows that he has appendicitis," he said.
"My condition is that they find
something in the partner that doesn't work [with the vaccine]. It will take
them one to two weeks to figure it out, and then maybe they'll have a trial in
a month," Booy said. Will resume hearing.
READ MORE
0 Comments